|
FDA, EMA Ramp Up Interactions, Search for New QbD Pilot Applicants
PHILADELPHIA — The FDA and the European Medicines Agency (EMA) are ramping up their interactions so they can more easily share information on future regulatory challenges, including foreign clinical trials, pharmacovigilance and active pharmaceutical ingredients.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives